Stocks · News reference
NeuroSense Therapeutics H1 EPS $(2.10) up From $(3.70) YoY
NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(2.10). This is a 43.24 percent increase over losses of $(3.70) per share from the same period last year.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
NeuroSense Therapeutics Announces 1-For-20 Reverse Stock Split, Effective Sept. 14
SEC. https://www.sec.gov/Archives/edgar/data/1875091/000121390026098414/ea0304823-6k_neurosense.htm
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage with Buy ratings on SpaceX, Securitize ; Overweight on Londian Wason.